Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
The great people I work with.
Quelles sont les meilleures choses à propos de votre équipe?
Most friendly welcoming team that I have worked with!
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Such a warm welcoming environment!
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Very teamwork oriented. The team strives to accomplish goals and milestones to better the company.
Other Employee Reviews for Karyopharm Therapeutics
×